Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Origin Materials, Inc. | Interim CFO | Common Stock | 137K | $106K | $0.77 | Sep 1, 2023 | Direct |
Arcadia Biosciences, Inc. | Chief Financial Officer | Stock Option (right to buy) | 255K | Aug 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ORGN | Origin Materials, Inc. | Sep 1, 2023 | 1 | $0 | 4 | Sep 6, 2023 | Interim CFO |
ORGN | Origin Materials, Inc. | Sep 1, 2023 | 0 | $0 | 3 | Sep 6, 2023 | Interim CFO |
RKDA | Arcadia Biosciences, Inc. | Aug 16, 2022 | 1 | $0 | 4 | Aug 18, 2022 | Chief Financial Officer |
RKDA | Arcadia Biosciences, Inc. | Aug 1, 2022 | 1 | $490 | 4 | Aug 3, 2022 | Chief Financial Officer |
RKDA | Arcadia Biosciences, Inc. | Apr 11, 2022 | 2 | $0 | 4 | Apr 13, 2022 | Chief Financial Officer |